U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
156481156481Digital Imaging Aid for Assessment of Cervical DysplasiaTerminatedNo Results AvailableCervical DysplasiaProcedure: Digital Imaginghttps://ClinicalTrials.gov/show/NCT00511758
156482156482Safety of Rabeprazole in Patients Under Multiple TreatmentsTerminatedNo Results AvailableGastroesophageal Reflux|Gastric UlcerDrug: Rabeprazolhttps://ClinicalTrials.gov/show/NCT00511745
15648315648318-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 DiabetesCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Technosphere Insulin|Drug: Technosphere Placebohttps://ClinicalTrials.gov/show/NCT00511732
156484156484Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 DiabetesCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Technosphere Insulin|Drug: Actrapidhttps://ClinicalTrials.gov/show/NCT00511719
156485156485Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)CompletedHas ResultsChoroidal Neovascularization|Age-Related MaculopathyDrug: dexamethasone|Biological: ranibizumab|Other: shamhttps://ClinicalTrials.gov/show/NCT00511706
156486156486Osteoporosis Coordinator for Low Volume Community HospitalsRecruitingNo Results AvailableOsteoporosis|Fragility FracturesBehavioral: centralized osteoporosis coordinator|Behavioral: fall preventionhttps://ClinicalTrials.gov/show/NCT00511693
156487156487Beat the Blues: Treating Depression in African American EldersCompletedNo Results AvailableDepression|Stress Reduction|Behavioral Activation TreatmentBehavioral: Behavioral Based In-Home Interventionhttps://ClinicalTrials.gov/show/NCT00511680
156488156488A Multiple Dose Investigational Drug Study in Patients With Type 2 Diabetes (MK-0941-005)CompletedHas ResultsType 2 Diabetes MellitusDrug: MK0941|Drug: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00511667
15648915648928-day Repeat Dose and Drug Interaction Study With Orvepitant (GW823296)CompletedNo Results AvailableHealthy SubjectsDrug: Orvepitanthttps://ClinicalTrials.gov/show/NCT00511654
156490156490Quality of Life Associated With a Low-Risk Screening Program for Ovarian CancerRecruitingNo Results AvailableOvarian CancerBehavioral: Questionnairehttps://ClinicalTrials.gov/show/NCT00511641
156491156491Study on the Safety of Risperidone on Obese or Overweight Patients With SchizophreniaTerminatedNo Results AvailableSchizophrenia|Schizoaffective Disorder|Schizophreniform DisorderDrug: Risperidonehttps://ClinicalTrials.gov/show/NCT00511628
156492156492Molecular Imaging for Detection of Cervical Intraepithelial NeoplasiaCompletedNo Results AvailableCervical CancerProcedure: Loop Electrosurgical Excision Procedure (LEEP)https://ClinicalTrials.gov/show/NCT00511615
156493156493Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 DiabetesCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Technosphere Insulin|Drug: Technosphere Placebohttps://ClinicalTrials.gov/show/NCT00511602
156494156494Chagas Disease Diagnostic - Inconclusive SerologyCompletedNo Results AvailableParasitemia|Protozoan InfectionsOther: chagas disease diagnostichttps://ClinicalTrials.gov/show/NCT00511589
156495156495Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsTerminatedNo Results AvailableBreast Cancer|Lung Cancer|Pulmonary Cancer|Non-Small-Cell Lung Carcinoma|Prostate Cancer|Prostatic Cancer|Gastric Cancer|Stomach CancerDrug: MGCD0103 & Docetaxelhttps://ClinicalTrials.gov/show/NCT00511576
156496156496A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679WithdrawnNo Results AvailableIrritable Bowel SyndromeDrug: GW876008 and GSK561679https://ClinicalTrials.gov/show/NCT00511563
156497156497Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated DonorsCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00511550
156498156498Unrelated Stem Cell Transplantation for Adults With Hematopoietic DisordersCompletedNo Results AvailableCML|ALL|AML|Myelodysplasia|Lymphoma|Myeloproliferative Disordershttps://ClinicalTrials.gov/show/NCT00511537
156499156499An Imaging Study to Investigate the Distribution of GW842166X in the Brain.CompletedNo Results AvailableAnalgesia|Inflammation|Pain, InflammatoryDrug: GW842166Xhttps://ClinicalTrials.gov/show/NCT00511524
156500156500Angiogenesis Inhibitors and Hypertension: Clinical AspectsCompletedNo Results AvailableHypertensionhttps://ClinicalTrials.gov/show/NCT00511511
156501156501Effect of Nightly Versus Prn Sildenafil on Early Return of Erectile Function Following Laparoscopic Radical ProstatectomyCompletedNo Results AvailableProstate CancerDrug: Sildenafilhttps://ClinicalTrials.gov/show/NCT00511498
156502156502Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03)CompletedNo Results AvailableAdenocarcinoma of the LungDrug: Vintafolide|Drug: Etarfolatidehttps://ClinicalTrials.gov/show/NCT00511485
156503156503An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)CompletedHas ResultsType 2 Diabetes MellitusDrug: MK-0941|Drug: Placebo|Drug: LANTUS insulinhttps://ClinicalTrials.gov/show/NCT00511472
156504156504Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer PatientsCompletedNo Results AvailableLocally Recurrent and Metastatic Breast CancerDrug: AMG 386 Placebo|Drug: AMG 386|Drug: Bevacizumab|Drug: AMG 386|Drug: AMG 386|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT00511459
156505156505Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric CancerCompletedNo Results AvailableStomach NeoplasmsDrug: docetaxel, oxaliplatin, capecitabinehttps://ClinicalTrials.gov/show/NCT00511446
156506156506Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)CompletedHas ResultsContraceptionDrug: NOMAC-E2|Drug: DRSP-EEhttps://ClinicalTrials.gov/show/NCT00511433
156507156507Effects of Cocoa Products on Cardiovascular Disease Risk FactorsCompletedNo Results AvailableCardiovascular DiseasesDietary Supplement: Cocoa product type 1|Dietary Supplement: Cocoa product type 2|Dietary Supplement: Cocoa product type 3|Dietary Supplement: Cocoa product type 4https://ClinicalTrials.gov/show/NCT00511420
156508156508Open-Label Study To Evaluate the Safety and Efficacy of the Renal Assist Device In Patients With Acute Renal FailureCompletedNo Results AvailableAcute Renal FailureDevice: Renal tubule assist devicehttps://ClinicalTrials.gov/show/NCT00511407
156509156509Acute Hemodynamics of Albumin Versus Normal Saline in CirrhosisSuspendedNo Results AvailableCirrhosis|AscitesDrug: 20% Human Albumin|Drug: Normal Salinehttps://ClinicalTrials.gov/show/NCT00511394
156510156510Genetic Testing in Detection of Late-Onset Hearing LossCompletedNo Results AvailableHearing Loss|Late-Onset Hearing Loss|DeafnessGenetic: No interventionhttps://ClinicalTrials.gov/show/NCT00511381

* Görseller ve İçerik tekif hakkına sahip olabilir